Pioneering the Global Commercialization of Precision Fermentation Fats

CABIO Biotech, in partnership with Nourish Ingredients, has successfully completed the first-ever global commercial production of precision fermentation-derived fats, marking a major breakthrough for the industry. This milestone validates the scalability and cost-effectiveness of precision fermentation, with CABIO’s expertise playing a crucial role in bringing this innovation to commercial reality.

This achievement represents a 1,700% increase in production capacity, enabling the supply of Tastilux®, a high-performance meaty fat that meets demand for 170,000 tonnes of end-product at minimal inclusion rates. While many in the industry continue to navigate scale-up challenges, CABIO and Nourish Ingredients have set a new benchmark for commercial feasibility in precision-fermented fats.

The successful commercialization of precision fermentation fats at this scale demonstrates an unparalleled cost advantage, reinforcing the economic viability of this technology. This breakthrough not only strengthens the partnership between CABIO and Nourish Ingredients but also paves the way for significant financial and strategic growth across the supply chain.

The first batch is now ready for global shipment across three continents, providing customers with rich, authentic animalic flavors and superior functionality for plant-based products. Initial feedback highlights exceptional flavor stability, ensuring the signature deep, meaty richness endures from the first bite to the last—delivering a sensory experience comparable to traditional animal fats.

By combining CABIO’s world-class fermentation expertise with Nourish Ingredients’ cutting-edge fat technology, this collaboration is driving a new era of sustainable, high-performance food ingredients at commercial scale. With this milestone, CABIO continues to advance the frontiers of precision fermentation, making delicious, sustainable food solutions more accessible than ever before.